Meet with KBI Biopharma at TIDES USA 2026 to discuss your unique CMC and manufacturing challenges for oligonucleotides and peptides. Connect with us on-site at the Hynes Convention Center to discover how KBI can serve as a dedicated collaborator for your drug development goals.
Schedule a meeting >>
Meet with KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
TIDES USA 2026 is North America's premier event for the oligonucleotide and peptide therapeutics industry, taking place from May 11–14 in Boston. This comprehensive forum brings together global leaders to share the latest science and best practices across the entire product lifecycle, from early-stage discovery and preclinical development to complex CMC, manufacturing, and commercialization strategies. With a technical agenda featuring six concurrent tracks, the conference also explores emerging innovations in mRNA, genome editing, and advanced drug delivery systems. It serves as a critical hub for researchers and CDMOs alike to collaborate on overcoming technical obstacles and accelerating the next generation of life-saving therapies to market.